NEW YORK CITY, NY / ACCESS Newswire / February 3, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims ...

“These innovations elevate the standard of care ... Inari Medical for $4.9bn" was originally created and published by Medical Device Network, a GlobalData owned brand. The information on this ...

Inari Medical stock skyrocketed Monday afternoon and again Tuesday morning after a report that it was close to being acquired by Stryker proved to be true, with the companies announcing the deal after ...

Stryker plans to acquire Inari Medical in a deal valued at $4.9 billion and designed to strength its position in the peripheral vascular market. The deal, announced Monday and approved by both ...

“These innovations elevate the standard of care for venous thromboembolism patients and will accelerate Stryker’s impact in endovascular procedures.” Inari had been working with advisers to ...

About Inari Medical, Inc. Patients first. No small plans. Take care of each other. These are the guiding principles that form the ethos of Inari Medical. We are committed to improving lives in ...

Stryker's acquisition of Inari for $4.9B enhances its neurovascular ... With that focus on “upstream” neurovascular care, Stryker has largely focused on neurosurgeons and has not really ...

You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> Inari Medical is part of the Zacks Medical - Instruments industry. Tandem Diabetes Care, Inc. TNDM, another ...